Biopool International Enters Into Four New Distribution Agreements.VENTURA, Calif.--(BUSINESS WIRE)--July 16, 1997--Biopool International (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :BIPL BIPL Biphase Level ) Wednesday announced that the company has entered into new agreements for the distribution of its BCA BCA Business Case Analysis BCA Building Code of Australia BCA Boeing Commercial Airplanes BCA Board of Contract Appeals BCA Boston Center for the Arts BCA Billiard Congress of America BCA Bureau of Criminal Apprehension BCA Breast Cancer Action immunohematology products in Germany, the United Kingdom, the Caribbean and Croatia/Slovenia. A new distribution agreement in Germany was entered into with Organon or·ga·non or or·ga·num n. pl. or·ga·nons or or·ga·nums or or·ga·na 1. An organ. 2. A set of principles for use in scientific investigation. organon pl. organa [Gr.] organ. Teknika Germany, which had been distributing the BCA immunohematology (blood group serology Serology The division of biological science concerned with antigen-antibody reactions in serum. It properly encompasses any of these reactions, but is often used in a limited sense to denote laboratory diagnostic tests, especially for syphilis. ) product line prior to Biopool's acquisition of the division from Organon Teknika. This new agreement, however, ensures continuity of this business in Germany, currently the largest export market for the BCA product line. In the United Kingdom, Bio-Stat Ltd. has been appointed as the new distributor of BCA immunohematology products. Bio-Stat has been distributing Biopool hemostasis hemostasis /he·mo·sta·sis/ (he?mo-sta´sis) (he-mos´tah-sis) 1. the arrest of bleeding by the physiological properties of vasoconstriction and coagulation or by surgical means. 2. products for the past five years and, with this new agreement, has now extended its available product line to include BCA products. Biopool has also entered into an agreement with F. Baragano Pharmaceuticals Inc. to distribute both immunohematology and hemostasis products in the territory of the Caribbean. Based in Puerto Rico Puerto Rico (pwār`tō rē`kō), island (2005 est. pop. 3,917,000), 3,508 sq mi (9,086 sq km), West Indies, c.1,000 mi (1,610 km) SE of Miami, Fla. , F. Baragano is an established and well-known supplier in the territory, handling a wide range of diagnostic reagents. In the territory of Croatia and Slovenia, Biopool has appointed Kalba d.o.o. as the company's new distributor of immunohematology products. Michael D. Bick, Ph.D., chairman and chief executive officer of Biopool, stated: "These agreements signal our continuing efforts to assure continuity of the immunohematology business, as in the case of Organon Teknika Germany, and to establish new dealers to expand our presence and market share worldwide. Numerous other agreements are under discussion and are expected to be finalized in the coming months." Founded in 1987, Biopool International develops, manufactures and markets a full range of test kits to assess and diagnose disorders of blood coagulation, thrombotic risk factors, fibrinolysis fibrinolysis /fi·bri·nol·y·sis/ (fi?brin-ol´i-sis) dissolution of fibrin by enzymatic action.fibrinolyt´ic fi·bri·nol·y·sis n. pl. , platelet function and the vascular system; specialty chemistry controls used to monitor and measure the presence of drugs of abuse; and blood group serology products used to screen for antibodies and group and type whole blood. The company's product line of more than 150 FDA-approved products are sold to hospitals, blood bank facilities, and clinical and reference laboratories on a worldwide basis through an extensive network of distributors. CONTACT: Biopool International Inc., Ventura Michael D. Bick/Carol Hill, 805/654-0643 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion